Please enable Javascript to use all features and improve your user experience.
EHC 2024
Programme
Posters
Search
EN
All people
Piero Barbanti
Sort by Type
Date
Speaker
ePoster
P204
Efficacy of fremanezumab treatment for migraine prevention in patients with migraine and major depressive disorder: results from the open-label extension of the UNITE study
Further involvements
ePoster
P054
Nationwide migraine trends in Italy: a study of demographic, social, and clinical insights from the I-GRAINE registry
ePoster
P171
Anti-CGRP monoclonal antibodies improve sleep quality in migraine patients – a 1-year, multicenter, longitudinal study
ePoster
P178
Migraine preventive treatment with eptinezumab improved patient-reported outcomes in patients with non-response on frequency of monthly migraine days
ePoster
P204
Efficacy of fremanezumab treatment for migraine prevention in patients with migraine and major depressive disorder: results from the open-label extension of the UNITE study
ePoster
P189
Real-world evaluation of Eptinezumab in Italy: effectiveness, tolerability, and safety in high-frequency and chronic migraine at 12 weeks – the EMBRACE study
v1.20.0
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy